TAMA SENICK: Open Payments
NPI 1942578414 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 53 payments from 15 companies in 2025. Trend: 2023 $1,849 · 2024 $2,185 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $185 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $133 |
| Ipsen Biopharmaceuticals, Inc | 1 | $105 |
| Madrigal Pharmaceuticals | 4 | $102 |
| Ardelyx, Inc. | 3 | $92 |
| Exact Sciences Corporation | 3 | $84 |
| Janssen Biotech, Inc. | 4 | $72 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| Ferring Pharmaceuticals Inc. | 2 | $47 |
Products named: XIFAXAN, IQIRVO, REZDIFFRA, IBSRELA, ENTYVIO, RINVOQ, TREMFYA, ZENPEP.
Industry payments across PA — which companies pay providers there.
